ALK and cancer: Although neuroblastoma is strongly associated with altered ALK signaling, ALK gain-of-function mice develop sympathetic ganglia hyperplasia and not cancer, and additional key triggers are necessary for cancer development, typically MYC amplification [40,41,42,43,44].